1. Home
  2. ASMB vs SAR Comparison

ASMB vs SAR Comparison

Compare ASMB & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$31.91

Market Cap

442.9M

Sector

Health Care

ML Signal

HOLD

Logo Saratoga Investment Corp New

SAR

Saratoga Investment Corp New

HOLD

Current Price

$22.03

Market Cap

360.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
SAR
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
442.9M
360.3M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ASMB
SAR
Price
$31.91
$22.03
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
$44.20
$23.75
AVG Volume (30 Days)
119.5K
100.9K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
14.34%
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$638.39
$0.39
P/E Ratio
N/A
$9.44
Revenue Growth
N/A
N/A
52 Week Low
$13.13
$20.78
52 Week High
$39.71
$25.64

Technical Indicators

Market Signals
Indicator
ASMB
SAR
Relative Strength Index (RSI) 64.78 43.57
Support Level $31.51 $21.40
Resistance Level $32.44 $23.74
Average True Range (ATR) 1.52 0.43
MACD 0.41 -0.13
Stochastic Oscillator 99.83 11.63

Price Performance

Historical Comparison
ASMB
SAR

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

About SAR Saratoga Investment Corp New

Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.

Share on Social Networks: